These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 19120529

  • 1. Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in localized prostate cancer: our first series of 100 patients.
    Tanaka N, Asakawa I, Kondo H, Tanaka M, Fujimoto K, Hasegawa M, Konishi N, Hirao Y.
    Int J Urol; 2009 Jan; 16(1):70-4. PubMed ID: 19120529
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
    D'Souza WD, Thames HD, Kuban DA.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1540-8. PubMed ID: 15050335
    [Abstract] [Full Text] [Related]

  • 4. The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer.
    Ash D, Al-Qaisieh B, Bottomley D, Carey B, Joseph J.
    Radiother Oncol; 2005 Jun 01; 75(3):303-6. PubMed ID: 15890423
    [Abstract] [Full Text] [Related]

  • 5. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P, Thissen B, Jansen N, Deneufbourg JM.
    Radiother Oncol; 2006 Jan 01; 78(1):47-52. PubMed ID: 16216365
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure].
    Toledano A, Chauveinc L, Flam T, Thiounn N, Solignac S, Timbert M, Rosenwald JC, Cosset JM.
    Cancer Radiother; 2007 May 01; 11(3):105-10. PubMed ID: 17158082
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation.
    Orio P, Wallner K, Merrick G, Herstein A, Mitsuyama P, Thornton K, Butler W, Sutlief S.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):342-6. PubMed ID: 17236959
    [Abstract] [Full Text] [Related]

  • 12. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry.
    Van Gellekom MP, Moerland MA, Van Vulpen M, Wijrdeman HK, Battermann JJ.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):772-80. PubMed ID: 15964707
    [Abstract] [Full Text] [Related]

  • 13. The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer.
    Ash D, Al-Qaisieh B, Bottomley D, Carey B, Joseph J.
    Radiother Oncol; 2006 May 01; 79(2):185-9. PubMed ID: 16701911
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dynamic dose-feedback prostate brachytherapy in patients with large prostates and/or planned transurethral surgery before implantation.
    Acher PL, Popert R, Morris SL, Potters L, Austin-Smith SL, Johnson UH, Nichol JE, Beaney RP.
    BJU Int; 2007 May 01; 99(5):1066-71. PubMed ID: 17233801
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High-dose regions versus likelihood of cure after prostate brachytherapy.
    Wallner K, Merrick G, Sutlief S, True L, Butler W.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):170-4. PubMed ID: 15850918
    [Abstract] [Full Text] [Related]

  • 18. Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer.
    Zaider M, Zelefsky MJ, Cohen GN, Chui CS, Yorke ED, Ben-Porat L, Happersett L.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):702-13. PubMed ID: 15708248
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Variations in international prostate symptom scores, uroflowmetric parameters, and prostate volume after (125)I permanent brachytherapy for localized prostate cancer.
    Tanaka N, Fujimoto K, Hirao Y, Asakawa I, Hasegawa M, Konishi N.
    Urology; 2009 Aug 01; 74(2):407-11. PubMed ID: 19376570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.